These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34697799)
1. Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia. Downes CEJ; Rehn J; Heatley SL; Yeung D; McClure BJ; White DL Br J Haematol; 2022 Feb; 196(3):700-705. PubMed ID: 34697799 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and Lee WY; Pfau RB; Choi SM; Yang J; Xiao H; Putnam EM; Ryan RJ; Bixby DL; Shao L Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238402 [TBL] [Abstract][Full Text] [Related]
3. JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. Van Roosbroeck K; Cox L; Tousseyn T; Lahortiga I; Gielen O; Cauwelier B; De Paepe P; Verhoef G; Marynen P; Vandenberghe P; De Wolf-Peeters C; Cools J; Wlodarska I Blood; 2011 Apr; 117(15):4056-64. PubMed ID: 21325169 [TBL] [Abstract][Full Text] [Related]
4. Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Maude SL; Tasian SK; Vincent T; Hall JW; Sheen C; Roberts KG; Seif AE; Barrett DM; Chen IM; Collins JR; Mullighan CG; Hunger SP; Harvey RC; Willman CL; Fridman JS; Loh ML; Grupp SA; Teachey DT Blood; 2012 Oct; 120(17):3510-8. PubMed ID: 22955920 [TBL] [Abstract][Full Text] [Related]
5. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis. Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722 [TBL] [Abstract][Full Text] [Related]
6. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Yoda A; Yoda Y; Chiaretti S; Bar-Natan M; Mani K; Rodig SJ; West N; Xiao Y; Brown JR; Mitsiades C; Sattler M; Kutok JL; DeAngelo DJ; Wadleigh M; Piciocchi A; Dal Cin P; Bradner JE; Griffin JD; Anderson KC; Stone RM; Ritz J; Foà R; Aster JC; Frank DA; Weinstock DM Proc Natl Acad Sci U S A; 2010 Jan; 107(1):252-7. PubMed ID: 20018760 [TBL] [Abstract][Full Text] [Related]
7. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan. Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene. Wouters Y; Nevejan L; Louwagie A; Devos H; Dewaele B; Selleslag D; Michaux L Br J Haematol; 2021 Feb; 192(4):e112-e115. PubMed ID: 33502001 [No Abstract] [Full Text] [Related]
9. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579 [TBL] [Abstract][Full Text] [Related]
10. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways. Fortschegger K; Husa AM; Schinnerl D; Nebral K; Strehl S Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299194 [TBL] [Abstract][Full Text] [Related]
11. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia. Poitras JL; Dal Cin P; Aster JC; Deangelo DJ; Morton CC Genes Chromosomes Cancer; 2008 Oct; 47(10):884-9. PubMed ID: 18618714 [TBL] [Abstract][Full Text] [Related]
12. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia. Schinnerl D; Fortschegger K; Kauer M; Marchante JR; Kofler R; Den Boer ML; Strehl S Blood; 2015 Feb; 125(8):1282-91. PubMed ID: 25515960 [TBL] [Abstract][Full Text] [Related]
13. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Lilljebjörn H; Henningsson R; Hyrenius-Wittsten A; Olsson L; Orsmark-Pietras C; von Palffy S; Askmyr M; Rissler M; Schrappe M; Cario G; Castor A; Pronk CJ; Behrendtz M; Mitelman F; Johansson B; Paulsson K; Andersson AK; Fontes M; Fioretos T Nat Commun; 2016 Jun; 7():11790. PubMed ID: 27265895 [TBL] [Abstract][Full Text] [Related]
14. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience. Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review. Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463 [TBL] [Abstract][Full Text] [Related]
16. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291 [TBL] [Abstract][Full Text] [Related]